Dixon Mitchell Investment Counsel’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-400
Closed -$49.8K 132
2024
Q2
$49.8K Hold
400
﹤0.01% 74
2024
Q1
$53.1K Buy
+400
New +$49.3K ﹤0.01% 82
2019
Q2
Sell
-74,338
Closed -$5.9M 64
2019
Q1
$5.9M Sell
74,338
-41,920
-36% -$3.14M 0.7% 44
2018
Q4
$8.48M Sell
116,258
-1,678
-1% -$118K 1.13% 28
2018
Q3
$7.98M Sell
117,936
-1,487
-1% -$94.7K 0.93% 35
2018
Q2
$6.92M Sell
119,423
-24,569
-17% -$1.39M 0.87% 34
2018
Q1
$7.48M Buy
143,992
+5,295
+4% +$286K 0.99% 34
2017
Q4
$7.45M Buy
138,697
+3,011
+2% +$167K 0.95% 34
2017
Q3
$8.29M Buy
135,686
+1,806
+1% +$109K 1.11% 27
2017
Q2
$8.19M Buy
133,880
+4,398
+3% +$268K 1.16% 27
2017
Q1
$7.85M Sell
129,482
-6,430
-5% -$390K 1.14% 29
2016
Q4
$7.63M Sell
135,912
-1,010
-0.7% -$59.1K 1.15% 27
2016
Q3
$8.15M Sell
136,922
-11,151
-8% -$652K 1.27% 27
2016
Q2
$8.14M Sell
148,073
-693
-0.5% -$36.9K 1.35% 26
2016
Q1
$7.51M Sell
148,766
-5,012
-3% -$245K 1.22% 29
2015
Q4
$7.75M Buy
153,778
+26,672
+21% +$1.34M 1.32% 26
2015
Q3
$5.99M Buy
127,106
+60,313
+90% +$3.2M 1.04% 28
2015
Q2
$3.63M Buy
+66,793
New +$3.75M 0.56% 47

Other funds holding MRK

Dixon Mitchell Investment Counsel's MRK Position: Q3 2024 in Review

Dixon Mitchell Investment Counsel sold out of Merck (MRK) in Q3 2024, closing a stake of 400 shares — an estimated $49.8K sold.

Dixon Mitchell Investment Counsel first reported a position in MRK in Q2 2015 and held it in 18 quarters. The position peaked at $8.48M in Q4 2018. 3,490 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Dixon Mitchell Investment Counsel reported no remaining Merck position as of Q3 2024 after selling out during the quarter.
  • Dixon Mitchell Investment Counsel sold 400 Merck shares in Q3 2024, an estimated $49.8K.
  • Dixon Mitchell Investment Counsel first reported a position in Merck in Q2 2015 and held it in 18 quarters.
  • Dixon Mitchell Investment Counsel's Merck position peaked at $8.48M in Q4 2018.
  • 3,490 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Dixon Mitchell Investment Counsel's 13F filing for Q3 2024, filed 17 Oct 2024.